Wondering if Exor could be excellent value right now? You're not alone, especially with mixed signals swirling in global markets. Exor's stock saw a modest 1.6% climb over the last week, but it's ...

Exor (ENXTAM:EXO) has quietly slipped over the past year, with shares down around 23% even as its underlying holdings like Ferrari and Stellantis keep executing. That gap is exactly what value focused ...

Philips resolved the Respironics litigation, settling for $1.1 billion. And Exor decided to boost its stake in the company. Supportive shareholders' remuneration is linked to Exor's portfolio results, ...

Exor’s FY24 performance was uninspiring, with Stellantis dragging down the very strong contribution from Ferrari. Recent actions—reducing Ferrari concentration, executing a large buyback, and ...

Has already invested almost 4 bln euros in healthcare Has cash firepower of 1.7 bln euros already allocated To receive around 1.1 bln euros in dividends during 2024 Exor NAV rose to 35.5 bln euros ...

MILAN, March 4 (Reuters) - Italy's Agnelli family has a 10.1% stake in New York-listed information services provider Clarivate 16A.F through their investment arm Exor EXOR.AS, the two companies said ...

Exor, the investment company controlled by Italy’s Agnelli family, said on Saturday its board had unanimously rejected an unsolicited approach from cryptocurrency group Tether to buy Exor’s stake in ...

Exor N.V. (OTC) ((NL:EXO)) has held its Q2 earnings call. Read on for the main highlights of the call. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, ...